About Lightship
Lightship is a company based in El Segundo (United States) founded in 1995 by Samantha Eells and Brian Lovett. It operates as a Professional Services and HealthTech. Lightship has raised $205.55 million across 4 funding rounds from investors including McKesson, Khosla Ventures and Brook Porter. The company has 74 employees as of December 31, 2013. Lightship offers products and services including Decentralized Trials, Hybrid Trials, Outreach & Recruitment, Mobile Research Units, and Mobile Nurses. Lightship operates in a competitive market with competitors including Clario, SFJ Pharmaceuticals, N-Power Medicine, Cognivia and Yunu, among others.
- Headquarter El Segundo, United States
- Employees 74 as on 31 Dec, 2013
- Founders Samantha Eells, Brian Lovett
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$205.55 M (USD)
in 4 rounds
-
Latest Funding Round
$135.55 M (USD), Series D
Feb 01, 2024
-
Investors
McKesson
& 5 more
-
Employee Count
74
as on Dec 31, 2013
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lightship
Lightship offers a comprehensive portfolio of products and services, including Decentralized Trials, Hybrid Trials, Outreach & Recruitment, Mobile Research Units, and Mobile Nurses.
Trials are delivered without geographical limits for inclusivity.
Hybrid studies are conducted with remote and site networks.
Representative populations are enrolled through community-based outreach models.
Community clinic settings are provided for study visits.
Home study visits are conducted by dedicated nurses.
People of Lightship
Unlock access to complete
Funding Insights of Lightship
Lightship has successfully raised a total of $205.55M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $135.55 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lightship
Lightship has secured backing from 6 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include McKesson, Khosla Ventures and Brook Porter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Define Ventures is focused on early-stage health tech investments.
|
Locked | Locked | Locked | |
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Investments are directed by McKesson Ventures toward early-stage healthcare startups.
|
Locked | Locked | Locked |
Investor details for Lightship
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lightship
Investment portfolio details for Lightship
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lightship
Detailed financials for Lightship
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lightship Comparisons
Peer comparison for Lightship
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lightship
Lightship operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clario, SFJ Pharmaceuticals, N-Power Medicine, Cognivia and Yunu, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CRO focused on providing clinical trial supply services for biopharma sector
|
|
| Locked | Locked | Locked |
Specialty pharmaceutical company based on partnering model
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to support medical research initiatives.
|
|
| Locked | Locked | Locked |
Provider of data modeling and patient insights for clinical trial optimization
|
|
| Locked | Locked | Locked |
Clinical trial imaging workflow and data management technology is provided.
|
Detailed competitors of Lightship
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lightship
Complete news archive for Lightship
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lightship
Lightship was founded in 1995 and raised its 1st funding round 25 years after it was founded.
Lightship is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
David MacMurchy is the current CEO of Lightship.
Lightship is a funded company, having raised a total of $205.55M across 4 funding rounds to date.
As of Dec 31, 2013, the latest employee count at Lightship is 74.
Clinical trial services are offered by Lightship, focusing on decentralized and hybrid trials to enhance access and inclusivity. Solutions are designed for biopharmaceutical sponsors, academic institutions, and CROs across the US and UK. Expertise is applied in therapeutic areas like cardiovascular disease, oncology, and rare diseases. Community-based outreach and mobile units are utilized to enroll representative populations. Patient-centered approaches are maintained from trial startup to close-out, ensuring high retention and diversity.
Lightship's top competitors include SFJ Pharmaceuticals, N-Power Medicine and Clario.
Lightship offers Decentralized Trials, Hybrid Trials, Outreach & Recruitment, Mobile Research Units, and Mobile Nurses.
Lightship has 6 investors. Key investors include McKesson, Khosla Ventures, Brook Porter, Define Ventures, and McKesson Ventures.